Table 1.
Patient characteristics, atopic comorbidities and severity of the most severe food allergy
| n (%) (n = 496) | |
|---|---|
| Gender: female (missing values: n = 3) | 349 (70%) |
| Mean age in years (SD, min‐max) (missing values: n = 1) | 33 (12.5, 16–79) |
| Atopic comorbidities | |
| Asthma, atopic dermatitis and/or allergic rhino conjunctivitis | 436 (88%) |
| Asthma (missing values: n = 12) | 302 (62%) |
| Atopic dermatitis (missing values: n = 52) | 232 (67%) |
| Allergic rhino conjunctivitis (missing values: n = 12) | 359 (74%) |
| Medication that could suppress allergic symptoms (on demand and daily use) | |
| Uses medication from ≥1 of the below medication groups | 334 (67%) |
| Systemic corticosteroids and/or immunosuppressive drugs | 46 (9%) |
| Antihistamines | 276 (56%) |
| Inhaled betamimetics | 118 (24%) |
| Inhaled corticosteroids | 108 (22%) |
| Emergency medication prescribed for food allergy 1 | |
| Antihistamines | 299 (60%) |
| Corticosteroids | 72 (15%) |
| Adrenaline auto‐injector | 154 (31%) |
| Emergency medication, type unknown | 13 (3%) |
| No emergency medication | 143 (29%) |
| Severity (Mueller) of the most severe food allergy | |
| Mueller 0 | 88 (18%) |
| Mueller I | 86 (17%) |
| Mueller 2 | 64 (13%) |
| Mueller 3 | 194 (39%) |
| Mueller 4 | 64 (13%) |
1
This data is reported by patients before the first consultation at the outpatient department Allergology.